Cell MedX (OTCMKTS:CMXC) Trading Down 0.4% – Here’s Why

Cell MedX Corp. (OTCMKTS:CMXC – Get Free Report) shares fell 0.4% on Monday . The stock traded as low as $0.3473 and last traded at $0.3473. 234 shares were traded during mid-day trading, a decline of 99% from the average session volume of 20,342 shares. The stock had previously closed at $0.3489.

Cell MedX Stock Down 0.4%

The company has a fifty day moving average of $0.31 and a two-hundred day moving average of $0.35.

About Cell MedX

(Get Free Report)

Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual.

Further Reading

• Five stocks we like better than Cell MedX
• These 5 Companies Just Made a Massive Bet on Themselves
• 5 Stocks Built to Thrive in a Higher-for-Longer Economy
• RH’s Strong Q1 Still Leaves Investors With One Big Question
• Iran Ceasefire or Not, These 3 Companies Could Win